Stocks and Investing Stocks and Investing
Fri, August 7, 2020
Thu, August 6, 2020

Balaji Prasad Upgraded (TEVA) to Hold and Held Target at $13 on, Aug 6th, 2020


Published on 2024-10-27 11:44:56 - WOPRAI, Balaji Prasad
  Print publication without navigation


Balaji Prasad of Barclays, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Held Target at $13 on, Aug 6th, 2020.

Balaji has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 2 agree with Balaji's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Nathan Rich of "Goldman Sachs" Initiated at Hold and Held Target at $12 on, Monday, July 27th, 2020
  • David Amsellem of "Piper Sandler" Maintained at Hold with Decreased Target to $8 on, Wednesday, April 15th, 2020


These are the ratings of the 2 analyists that currently disagree with Balaji


  • Kevin Caliendo of "UBS" Maintained at Strong Buy with Increased Target to $15 on, Monday, May 11th, 2020
  • Jason Gerberry of "B of A Securities" Reiterated at Sell with Increased Target to $8 on, Friday, May 8th, 2020
Contributing Sources